Establishment and Validation of a Time-Resolved Fluoroimmunoassay for Chlorpromazine
暂无分享,去创建一个
Kai Zhang | Minhao Xie | Biao Huang | Jian Jin | Jue Zhang | Lili Zhao | J. Sun | Yi Zhang
[1] J. Trachtman,et al. Sanitary and Phytosanitary Measures , 2021, The Law and Policy of the World Trade Organization.
[2] B. Rezaei,et al. Chemiluminescence determination of chlorpromazine and fluphenazine in pharmaceuticals and human serum using tris(1,10-phenanthroline) ruthenium(II) , 2011 .
[3] H. Aboul‐Enein,et al. A simple and reliable stir bar sorptive extraction-liquid chromatography procedure for the determination of chlorpromazine and trifluoperazine in human serum using experimental design methodology. , 2011, Journal of separation science.
[4] J. Molnár,et al. Phenothiazines, bacterial efflux pumps and targeting the macrophage for enhanced killing of intracellular XDRTB. , 2010, In vivo.
[5] Hailin Yang,et al. Dual-label time-resolved fluoroimmunoassay for simultaneous detection of aflatoxin B1 and ochratoxin A , 2009, Archives of Toxicology.
[6] K. Mealey. Therapeutic implications of the MDR-1 gene. , 2004, Journal of veterinary pharmacology and therapeutics.
[7] C. Elliott,et al. Development of a rapid screening test for veterinary sedatives and the beta-blocker carazolol in porcine kidney by ELISA. , 2004, The Analyst.
[8] S. Daunert,et al. Class-selective drug detection: fluorescently-labeled calmodulin as the biorecognition element for phenothiazines and tricyclic antidepressants. , 2002, Bioconjugate chemistry.
[9] K. Takagi,et al. Bioelectric toxicity caused by chlorpromazine in human lung epithelial cells. , 2002, Toxicology and applied pharmacology.
[10] T. Jones,et al. Atherosclerotic Risks from Chemicals: Part I. Toxicological Observations and Mechanisms of Atherosclerosis , 1998, Archives of environmental contamination and toxicology.
[11] Richard I. Christopherson,et al. Chlorpromazine transport in membrane vesicles from multidrug resistant CCRF‐CEM cells , 1996, Biochemistry and molecular biology international.
[12] T. Lövgren,et al. Europium as a label in time-resolved immunofluorometric assays. , 1984, Analytical biochemistry.
[13] L. Hollister. Human pharmacology of antipsychotic and antidepressant drugs. , 1968, Annual review of pharmacology.
[14] R. M. Quinton. THE INCREASE IN THE TOXICITY OF YOHIMBINE INDUCED BY IMIPRAMINE AND OTHER DRUGS IN MICE. , 1963, British journal of pharmacology and chemotherapy.